The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Drug resistance in influenza A virus: the epidemiology and management
Open accessAbstract
Influenza A virus (IAV) is the sole cause of the unpredictable influenza pandemics and deadly zoonotic outbreaks and constitutes at least half of the cause of regular annual influenza epidemics in humans. Two classes of anti-IAV drugs, adamantanes and neuraminidase (NA) inhibitors (NAIs) targeting the viral components M2 ion channel and NA, respectively, have been approved to treat IAV infections. However, IAV rapidly acquired resistance against both classes of drugs by mutating these viral components. The adamantane-resistant IAV has established itself in nature, and a majority of the IAV subtypes, especially the most common H1N1 and H3N2, circulating globally are resistant to adamantanes. Consequently, adamantanes have become practically obsolete as anti-IAV drugs. Similarly, up to 100% of the globally circulating IAV H1N1 subtypes were resistant to oseltamivir, the most commonly used NAI, until 2009. However, the 2009 pandemic IAV H1N1 subtype, which was sensitive to NAIs and has now become one of the dominant seasonal influenza virus strains, has replaced the pre-2009 oseltamivir-resistant H1N1 variants. This review traces the epidemiology of both adamantane- and NAI-resistant IAV subtypes since the approval of these drugs and highlights the susceptibility status of currently circulating IAV subtypes to NAIs. Further, it provides an overview of currently and soon to be available control measures to manage current and emerging drug-resistant IAV. Finally, this review outlines the research directions that should be undertaken to manage the circulation of IAV in intermediate hosts and develop effective and alternative anti-IAV therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Evolution and ecology of influenza A viruses
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992) · Microbiological Reviews · doi:10.1128/mr.56.1.152-179.1992 · Cited by 4,739
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903810 · Cited by 3,037
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Neumann, G., Noda, T., & Kawaoka, Y. (2009) · Nature · doi:10.1038/nature08157 · Cited by 1,561
New World Bats Harbor Diverse Influenza A Viruses
Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., Gomez, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003657 · Cited by 1,351
A review of avian influenza in different bird species
Alexander, D. J. (2000) · Veterinary Microbiology · doi:10.1016/s0378-1135(00)00160-7 · Cited by 1,272
Influenza virus M2 protein has ion channel activity
Pinto, L. H., Holsinger, L. J., & Lamb, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90452-i · Cited by 1,213
The biology of influenza viruses
Bouvier, N. M., & Palese, P. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.039 · Cited by 1,186
A distinct lineage of influenza A virus from bats
Tong, S., Li, Y., Rivailler, P., Conrardy, C., Castillo, D. A. A., Chen, L.-M., Recuenco, S., Ellison, J. A., Davis, C. T., York, I. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116200109 · Cited by 1,103
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100
Neuraminidase Inhibitors for Influenza
Moscona, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050740 · Cited by 1,094
Structure and mechanism of the M2 proton channel of influenza A virus
Schnell, J. R., & Chou, J. J. (2008) · Nature · doi:10.1038/nature06531 · Cited by 1,067
Molecular Basis for the Generation in Pigs of Influenza A Viruses with Pandemic Potential
Ito, T., Couceiro, J. N. S. S., Kelm, S., Baum, L. G., Krauss, S., Castrucci, M. R., Donatelli, I., Kida, H., Paulson, J. C., Webster, R. G., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7367-7373.1998 · Cited by 1,028
Nair, H., Brooks, W. A., Katz, M., Roca, A., Berkley, J. A., Madhi, S. A., Simmerman, J. M., Gordon, A., Sato, M., Howie, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61051-9 · Cited by 1,006
The genomic and epidemiological dynamics of human influenza A virus
Rambaut, A., Pybus, O. G., Nelson, M. I., Viboud, C., Taubenberger, J. K., & Holmes, E. C. (2008) · Nature · doi:10.1038/nature06945 · Cited by 925
Vaccines for preventing influenza in healthy adults
Jefferson, T., Di Pietrantonj, C., Rivetti, A., Bawazeer, G. A., Al-Ansary, L. A., & Ferroni, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub4 · Cited by 896
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution
Varghese, J. N., Laver, W. G., & Colman, P. M. (1983) · Nature · doi:10.1038/303035a0 · Cited by 891
The molecular basis of the specific anti-influenza action of amantadine.
Hay, A. J., Wolstenholme, A. J., Skehel, J. J., & Smith, M. H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04038.x · Cited by 847
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Russell, R. J., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., & Skehel, J. J. (2006) · Nature · doi:10.1038/nature05114 · Cited by 813
Structure of the catalytic and antigenic sites in influenza virus neuraminidase
Colman, P. M., Varghese, J. N., & Laver, W. G. (1983) · Nature · doi:10.1038/303041a0 · Cited by 798
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 789
Resistant influenza A viruses in children treated with oseltamivir: descriptive study
Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 786
Influenza virus neuraminidase inhibitors
Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11433-8 · Cited by 730
Bright, R. A., Medina, M.-J., Xu, X., Perez-Oronoz, G., Wallis, T. R., Davis, X. M., Povinelli, L., Cox, N. J., & Klimov, A. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67338-2 · Cited by 725
Oral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Isolation of drug-resistant H5N1 virus
Le, Q. M., Kiso, M., Someya, K., Sakai, Y. T., Nguyen, T. H., Nguyen, K. H. L., Pham, N. D., Ngyen, H. H., Yamada, S., Muramoto, Y., et al. (2005) · Nature · doi:10.1038/4371108a · Cited by 693
Bright, R. A. (2006) · JAMA · doi:10.1001/jama.295.8.joc60020 · Cited by 671
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Bloom, J. D., Gong, L. I., & Baltimore, D. (2010) · Science · doi:10.1126/science.1187816 · Cited by 649
Structural basis for the function and inhibition of an influenza virus proton channel
Stouffer, A. L., Acharya, R., Salom, D., Levine, A. S., Di Costanzo, L., Soto, C. S., Tereshko, V., Nanda, V., Stayrook, S., & DeGrado, W. F. (2008) · Nature · doi:10.1038/nature06528 · Cited by 636
Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers
Cady, S. D., Schmidt-Rohr, K., Wang, J., Soto, C. S., DeGrado, W. F., & Hong, M. (2010) · Nature · doi:10.1038/nature08722 · Cited by 615
Advances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 597
Zhou, H., Thompson, W. W., Viboud, C. G., Ringholz, C. M., Cheng, P.-Y., Steiner, C., Abedi, G. R., Anderson, L. J., Brammer, L., & Shay, D. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis211 · Cited by 573
Deyde, V. M., Xu, X., Bright, R. A., Shaw, M., Smith, C. B., Zhang, Y., Shu, Y., Gubareva, L. V., Cox, N. J., & Klimov, A. I. (2007) · The Journal of Infectious Diseases · doi:10.1086/518936 · Cited by 543
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Collins, P. J., Haire, L. F., Lin, Y. P., Liu, J., Russell, R. J., Walker, P. A., Skehel, J. J., Martin, S. R., Hay, A. J., & Gamblin, S. J. (2008) · Nature · doi:10.1038/nature06956 · Cited by 534
Influenza virus pleiomorphy characterized by cryoelectron tomography
Harris, A., Cardone, G., Winkler, D. C., Heymann, J. B., Brecher, M., White, J. M., & Steven, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607614103 · Cited by 529
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Dharan, N. J. (2009) · JAMA · doi:10.1001/jama.2009.294 · Cited by 527
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
Dolin, R., Reichman, R. C., Madore, H. P., Maynard, R., Linton, P. N., & Webber-Jones, J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209023071002 · Cited by 501
Sheu, T. G., Deyde, V. M., Okomo-Adhiambo, M., Garten, R. J., Xu, X., Bright, R. A., Butler, E. N., Wallis, T. R., Klimov, A. I., & Gubareva, L. V. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00555-08 · Cited by 480
The M2 Proton Channels of Influenza A and B Viruses
Pinto, L. H., & Lamb, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r500020200 · Cited by 459
Early administration of oral oseltamivir increases the benefits of influenza treatment
Aoki, F. Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg007 · Cited by 424
Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
Hayden, F. G., Belshe, R. B., Clover, R. D., Hay, A. J., Oakes, M. G., & Soo, W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212502 · Cited by 416
Evolution of H5N1 Avian Influenza Viruses in Asia
The World Health Organization Global Influenza Program Surveillance Network (2005) · Emerging Infectious Diseases · doi:10.3201/eid1110.050644 · Cited by 415
Continuing challenges in influenza
Webster, R. G., & Govorkova, E. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12462 · Cited by 399
Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance
McKimm‐Breschkin, J. L. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12047 · Cited by 390
Babu, Y. S., Chand, P., Bantia, S., Kotian, P., Dehghani, A., El-Kattan, Y., Lin, T.-H., Hutchison, T. L., Elliott, A. J., Parker, C. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002679 · Cited by 384
Traditional and New Influenza Vaccines
Wong, S.-S., & Webby, R. J. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00097-12 · Cited by 372
Bat-derived influenza-like viruses H17N10 and H18N11
Wu, Y., Wu, Y., Tefsen, B., Shi, Y., & Gao, G. F. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.01.010 · Cited by 365
Monto, A. S., McKimm-Breschkin, J. L., Macken, C., Hampson, A. W., Hay, A., Klimov, A., Tashiro, M., Webster, R. G., Aymard, M., Hayden, F. G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01339-05 · Cited by 364
Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
Meijer, A., Lackenby, A., Hungnes, O., Lina, B., van der Werf, S., Schweiger, B., Opp, M., Paget, J., van de Kassteele, J., Hay, A. J., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1504.081280 · Cited by 362
Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae
Gottschalk, A. (1957) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(57)90389-x · Cited by 360
Pinto, L. H., Dieckmann, G. R., Gandhi, C. S., Papworth, C. G., Braman, J., Shaughnessy, M. A., Lear, J. D., Lamb, R. A., & DeGrado, W. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11301 · Cited by 352
Neuzil, K. M., Hohlbein, C., & Zhu, Y. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.10.986 · Cited by 345
Influenza virus neuraminidase: Structure, antibodies, and inhibitors
Colman, P. M. (1994) · Protein Science · doi:10.1002/pro.5560031007 · Cited by 333
Resistance of influenza viruses to neuraminidase inhibitors — a review
MCKIMMBRESCHKIN, J. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00103-0 · Cited by 320
Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
Gubareva, L. V., Kaiser, L., Matrosovich, M. N., Soo‐Hoo, Y., & Hayden, F. G. (2001) · The Journal of Infectious Diseases · doi:10.1086/318537 · Cited by 318
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe
Lackenby, A., Hungnes, O., Dudman, S. G., Meijer, A., Paget, W. J., Hay, A. J., & Zambon, M. C. (2008) · Eurosurveillance · doi:10.2807/ese.13.05.08026-en · Cited by 318
Influenza virus morphogenesis and budding
Nayak, D. P., Balogun, R. A., Yamada, H., Zhou, Z. H., & Barman, S. (2009) · Virus Research · doi:10.1016/j.virusres.2009.05.010 · Cited by 301
Mechanism of drug inhibition and drug resistance of influenza A M2 channel
Pielak, R. M., Schnell, J. R., & Chou, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902548106 · Cited by 294
McKimm-Breschkin, J., Trivedi, T., Hampson, A., Hay, A., Klimov, A., Tashiro, M., Hayden, F., & Zambon, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2264-2272.2003 · Cited by 291
Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid
Meindl, P., Bodo, G., Palese, P., Schulman, J., & Tuppy, H. (1974) · Virology · doi:10.1016/0042-6822(74)90080-4 · Cited by 287
Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
Belshe, R. B., Smith, M. H., Hall, C. B., Betts, R., & Hay, A. J. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1508-1512.1988 · Cited by 287
Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus
Worobey, M., Han, G.-Z., & Rambaut, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324197111 · Cited by 286
Plaque inhibition assay for drug susceptibility testing of influenza viruses
Hayden, F. G., Cote, K. M., & Douglas, R. G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.5.865 · Cited by 278
Hurt, A. C., Ernest, J., Deng, Y.-M., Iannello, P., Besselaar, T. G., Birch, C., Buchy, P., Chittaganpitch, M., Chiu, S.-C., Dwyer, D., et al. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.03.003 · Cited by 277
Hurt, A. C., Besselaar, T. G., Daniels, R. S., Ermetal, B., Fry, A., Gubareva, L., Huang, W., Lackenby, A., Lee, R. T. C., Lo, J., et al. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.06.001 · Cited by 270
The Gate of the Influenza Virus M2 Proton Channel Is Formed by a Single Tryptophan Residue
Tang, Y., Zaitseva, F., Lamb, R. A., & Pinto, L. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206582200 · Cited by 249
Yen, H.-L., Herlocher, L. M., Hoffmann, E., Matrosovich, M. N., Monto, A. S., Webster, R. G., & Govorkova, E. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4075-4084.2005 · Cited by 248
Dong, G., Peng, C., Luo, J., Wang, C., Han, L., Wu, B., Ji, G., & He, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119115 · Cited by 243
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors
Oxford, J. S., Bossuyt, S., Balasingam, S., Mann, A., Novelli, P., & Lambkin, R. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00564.x · Cited by 233
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Hurt, A. C., Holien, J. K., Parker, M., Kelso, A., & Barr, I. G. (2009) · Journal of Virology · doi:10.1128/jvi.01200-09 · Cited by 233
Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08
Hauge, S. H., Dudman, S., Borgen, K., Lackenby, A., & Hungnes, O. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1502.081031 · Cited by 233
Influenza cost and cost-effectiveness studies globally – A review
Peasah, S. K., Azziz-Baumgartner, E., Breese, J., Meltzer, M. I., & Widdowson, M.-A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.013 · Cited by 232
Hurt, A. C., Chotpitayasunondh, T., Cox, N. J., Daniels, R., Fry, A. M., Gubareva, L. V., Hayden, F. G., Hui, D. S., Hungnes, O., Lackenby, A., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70318-8 · Cited by 228
Global Mortality Impact of the 1957–1959 Influenza Pandemic
Viboud, C., Simonsen, L., Fuentes, R., Flores, J., Miller, M. A., & Chowell, G. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv534 · Cited by 228
Yamashita, M., Tomozawa, T., Kakuta, M., Tokumitsu, A., Nasu, H., & Kubo, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00333-08 · Cited by 216
Suppression of Avian Influenza Transmission in Genetically Modified Chickens
Lyall, J., Irvine, R. M., Sherman, A., McKinley, T. J., Núñez, A., Purdie, A., Outtrim, L., Brown, I. H., Rolleston-Smith, G., Sang, H., et al. (2011) · Science · doi:10.1126/science.1198020 · Cited by 203
The epidemiology and spread of drug resistant human influenza viruses
Hurt, A. C. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.04.009 · Cited by 199
Vaccines for preventing influenza in healthy adults
Demicheli, V., Jefferson, T., Al-Ansary, L. A., Ferroni, E., Rivetti, A., & Di Pietrantonj, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub5 · Cited by 195
Simonsen, L., Viboud, C., Grenfell, B. T., Dushoff, J., Jennings, L., Smit, M., Macken, C., Hata, M., Gog, J., Miller, M. A., et al. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm103 · Cited by 185
Resistance of Influenza A Virus to Amantadine and Rimantadine: Results of One Decade of Surveillance
Belshe, R. B., Burk, B., Newman, F., Cerruti, R. L., & Sim, I. S. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.3.430 · Cited by 174
Stephenson, I., Democratis, J., Lackenby, A., McNally, T., Smith, J., Pareek, M., Ellis, J., Bermingham, A., Nicholson, K., & Zambon, M. (2009) · Clinical Infectious Diseases · doi:10.1086/596311 · Cited by 174
Abed, Y., Goyette, N., & Boivin, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.556-559.2005 · Cited by 171
Barberis, I., Myles, P. R., Ault, S. K., Bragazzi, N. L., & Martini, M. (2016) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2016.57.3.642 · Cited by 170
Influenza Virus Neuraminidase: Structure and Function
Shtyrya, Y. A., Mochalova, L. V., & Bovin, N. V. (2009) · Acta Naturae · doi:10.32607/20758251-2009-1-2-26-32 · Cited by 167
Takashita, E., Meijer, A., Lackenby, A., Gubareva, L., Rebelo-de-Andrade, H., Besselaar, T., Fry, A., Gregory, V., Leang, S.-K., Huang, W., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.02.003 · Cited by 158
Pizzorno, A., Bouhy, X., Abed, Y., & Boivin, G. (2010) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq010 · Cited by 157
Memoli, M. J., Hagey, R. J., Hassantoufighi, A., Eichelberger, M. C., & Taubenberger, J. K. (2010) · Clinical Infectious Diseases · doi:10.1086/651605 · Cited by 154
Position statement: global neuraminidase inhibitor susceptibility network
Zambon, M. C. F. A., & Hayden, F. G. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00124-3 · Cited by 153
Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus
Yamayoshi, S., Watanabe, M., Goto, H., & Kawaoka, Y. (2015) · Journal of Virology · doi:10.1128/jvi.02175-15 · Cited by 148
Excess Mortality Associated With Influenza A and B Virus in Hong Kong, 1998–2009
Wu, P., Goldstein, E., Ho, L., Yang, L., Nishiura, H., Wu, J. T. K., Ip, D., Chuang, S. K., Tsang, T., & Cowling, B. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis628 · Cited by 135
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly
Gasparini, R., Amicizia, D., Lai, P. L., & Panatto, D. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.8.1.17622 · Cited by 134
Tramontana, A. R., George, B., Hurt, A. C., Doyle, J. S., Langan, K., Reid, A. B., Harper, J. M., Thursky, K., Worth, L. J., Dwyer, D. E., et al. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1607.091691 · Cited by 127
Structural basis for oseltamivir resistance of influenza viruses
Collins, P. J., Haire, L. F., Lin, Y., Liu, J., Russell, R. J., Walker, P. A., Martin, S. R., Daniels, R. S., Gregory, V., Skehel, J. J., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.017 · Cited by 121
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses
Nelson, M. I., Simonsen, L., Viboud, C. G., Miller, M. A., & Holmes, E. C. (2009) · Virology · doi:10.1016/j.virol.2009.03.026 · Cited by 117
Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A Viruses
Ziegler, T. T., Hemphill, M. L., Ziegler, M., Perez‐Oronoz, G., Klimov, A. I., Hampson, A. W., Regnery, H. L., & Cox, N. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314994 · Cited by 113
Hurt, A. C., Barr, I., Härtel, G., & Hampson, A. W. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.11.008 · Cited by 104
Yu, H., Huang, J., Huai, Y., Guan, X., Klena, J. D., Liu, S., Peng, Y., Yang, H., Luo, J. F., Zheng, J., et al. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12205 · Cited by 102
Furuse, Y., Suzuki, A. K., & Oshitani, H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00650-09 · Cited by 98
Ilyushina, N. A., Seiler, J. P., Rehg, J. E., Webster, R. G., & Govorkova, E. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000933 · Cited by 96
Avian influenza A H5N1 virus: a continuous threat to humans
To, K. K., Ng, K. H., Que, T., Chan, J. M., Tsang, K.-Y., Tsang, A. K. L., Chen, H., & Yuen, K. (2012) · Emerging Microbes & Infections · doi:10.1038/emi.2012.24 · Cited by 96
Escuret, V., Frobert, É., Bouscambert‐Duchamp, M., Sabatier, M., Grog, I., Valette, M., Lina, B., Morfin, F., & Ferraris, O. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.10.019 · Cited by 86
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A
Reuman, P. D., Bernstein, D. I., Keefer, M. C., Young, E. C., Sherwood, J. R., & Schiff, G. M. (1989) · Antiviral Research · doi:10.1016/0166-3542(89)90018-1 · Cited by 85
Antiviral therapies on the horizon for influenza
Naesens, L. M. J., Stevaert, A., & Vanderlinden, E. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.08.003 · Cited by 80
Burden of influenza in Latin America and the Caribbean: a systematic review and meta‐analysis
Savy, V., Ciapponi, A., Bardach, A., Glujovsky, D., Aruj, P. K., Mazzoni, A., Gibbons, L., Ortega‐Barría, E., & Colindres, R. E. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12036 · Cited by 76
Peramivir: an intravenous neuraminidase inhibitor
McLaughlin, M. M., Skoglund, E. W., & Ison, M. G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1066336 · Cited by 75
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance
Moss, R. B., Davey, R. T., Steigbigel, R. T., & Fang, F. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq100 · Cited by 74
Current and novel antiviral strategies for influenza infection
Yen, H. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.05.004 · Cited by 68
Duan, S., Govorkova, E. A., Bahl, J., Zaraket, H., Baranovich, T., Seiler, P., Prevost, K., Webster, R. G., & Webby, R. J. (2014) · Nature Communications · doi:10.1038/ncomms6029 · Cited by 67
Structural Analysis of Influenza A Virus Matrix Protein M1 and Its Self-Assemblies at Low pH
Shtykova, E. V., Baratova, L. A., Fedorova, N. V., Radyukhin, V. A., Ksenofontov, A. L., Волков, В. В., Shishkov, A. V., Dolgov, A., Shilova, L. A., Batishchev, O. V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082431 · Cited by 67
Burden of influenza‐associated deaths in the Americas, 2002–2008
Cheng, P., Palekar, R. S., Azziz‐Baumgartner, E., Iuliano, A. D., Alencar, A. P., Bresee, J., Oliva, O., de Souza, M. D. F. M., & Widdowson, M. (2015) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12317 · Cited by 64
THE INHIBITION OF NEURAMINIDASE AND ANTIVIRAL ACTION
EDMOND, J. D., JOHNSTON, R. G., Kidd, D. A. A., Rylance, H. J., & Sommerville, R. G. (1966) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1966.tb01673.x · Cited by 62
Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus
Sears, S. D., & Clements, M. L. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.10.1470 · Cited by 57
Okomo‐Adhiambo, M., Sleeman, K., Lysén, C., Nguyen, H., Xu, X., Li, Y., Klimov, A. I., & Gubareva, L. V. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12113 · Cited by 55
Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong
Leung, T. W. C., Tai, A. L. S., Cheng, P. K. C., et al. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.08.004 · Cited by 55
Kyeyagalire, R., Tempia, S., Cohen, A. L., Smith, A. D., McAnerney, J. M., Msimang, V., & Cohen, C. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0694-x · Cited by 55
Harvala, H., Gunson, R. N., Simmonds, P., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.14.19536-en · Cited by 54
Tamura, D., Sugaya, N., Ozawa, M., Takano, R., Ichikawa, M., Yamazaki, M., Kawakami, C., Shimizu, H., Uehara, R., Kiso, M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq183 · Cited by 51
McKimm‐Breschkin, J. L., & Fry, A. M. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.01.012 · Cited by 51
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
Kashiwagi, S., Ohashi, A. W. S.-C. C. M. J. K. D. W.-S. C. Y., Ikematsu, H., Uemori, M., & Awamura, S. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw255 · Cited by 51
Avian influenza A (H7N9) virus infection in humans: Epidemiology, evolution, and pathogenesis
Husain, M. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.10.016 · Cited by 47
Self-citationRare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
Dapat, C., Suzuki, Y. A., Saito, R., et al. (2010) · Emerging infectious diseases · doi:10.3201/eid1603.091321 · Cited by 47
The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population
Young‐Xu, Y., van Aalst, R., Russo, E. M., Lee, J. K. H., & Chit, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169344 · Cited by 47
Breteler, J. K., Tam, J. S., Jit, M., Ket, J. C. F., & de Boer, M. R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.056 · Cited by 46
A new concept of the epidemic process of influenza A virus
Hope-Simpson, R. E., & Db, G. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066851 · Cited by 46
Influenza-Related Hospitalization and ED Visits in Children Less Than 5 Years: 2000–2011
Jules, A., Grijalva, C. G., Zhu, Y., Talbot, H. K., Williams, J. V., Poehling, K. A., Chaves, S. S., Edwards, K. M., Schaffner, W., Shay, D. K., et al. (2014) · PEDIATRICS · doi:10.1542/peds.2014-1168 · Cited by 44
Where does amantadine bind to the influenza virus M2 proton channel?
Kozakov, D., Chuang, G., Beglov, D., & Vajda, S. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.03.006 · Cited by 43
Garcia, V., & Aris‐Brosou, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst204 · Cited by 42
Chiu, S. S. S., Chan, K., So, L. Y., Chen, R. Y., Chan, E. L. Y., & Peiris, M. J. S. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.027 · Cited by 37
Human–Animal Interface: The Case for Influenza Interspecies Transmission
Donatelli, I., Castrucci, M. R., Marco, M. A. D., Delogu, M., & Webster, R. G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_136 · Cited by 37
Li, Q., Qi, J., Wu, Y., Kiyota, H., Tanaka, K., Suhara, Y., Ohrui, H., Suzuki, Y., Vavricka, C. J., & Gao, G. F. (2013) · Journal of Virology · doi:10.1128/jvi.01129-13 · Cited by 35
Chadha, M., Hirve, S. S., Dawood, F. S., Lele, P., Deoshatwar, A., Sambhudas, S., Juvekar, S. K., Lafond, K. E., Mott, J. A., Lal, R. B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055918 · Cited by 30
Cowling, B. J., Feng, S., Finelli, L., Steffens, A., & Fowlkes, A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.016 · Cited by 30
Wu, Y., Gao, F., Qi, J., Bi, Y., Fu, L., Mohan, S., Chen, Y., Li, X., Pinto, B. M., Vavricka, C. J., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01703-16 · Cited by 30
Recombinant hemagglutinin influenza vaccine provides broader spectrum protection
Dunkle, L. M., & Izikson, R. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1203261 · Cited by 29
Germline Modification and Engineering in Avian Species
Lee, H. J., Lee, H. C., & Han, J. Y. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0225 · Cited by 27
Cooper, B. S., Kotirum, S., Kulpeng, W., Praditsitthikorn, N., Chittaganpitch, M., Limmathurotsakul, D., Day, N. P. J., Coker, R., Teerawattananon, Y., & Meeyai, A. C. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu360 · Cited by 22
Wang, S., Chen, C., Zhou, Y., Chi, X., Zhang, J., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep23746 · Cited by 15
Cited by
Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00878-2 · Cited by 1,179
A brief review of influenza virus infection
Javanian, M., Barary, M., Ghebrehewet, S., Koppolu, V., Vasigala, V., & Ebrahimpour, S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26990 · Cited by 458
Evolution of Influenza A Virus by Mutation and Re-Assortment
Shao, W., Li, X., Goraya, M., Wang, S., & Chen, J.-L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081650 · Cited by 427
Influenza and antiviral resistance: an overview
Lampejo, T. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03840-9 · Cited by 342
Toots, M., Yoon, J.-J., Cox, R. M., Hart, M., Sticher, Z. M., Makhsous, N., Plesker, R., Barrena, A. H., Reddy, P. G., Mitchell, D. G., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5866 · Cited by 326
Metadata
- Authors
- Hussain, M., Galvin, H., Haw, T. Y., Nutsford, A., & Husain, M.
- Venue
- Infection and Drug Resistance
- Publisher
- Informa UK Limited
- Published
- 2017-04
- Volume
- Volume 10
- Pages
- 121-134
- ISSN
- 1178-6973 (ISSN-L)
- OpenAlex
- W2606218024
- Cited by
- 439
- References
- 141
- FWCI
- 28.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.